Clinical Trial Update: Adult Attention Deficit Hyperactivity Disorder (ADHD) Study With Amphetamine Sulfate [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating amphetamine sulfate for adults with attention-deficit/hyperactivity disorder has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• Amphetamine sulfate (amphetamine sulfate)

Snippet

Sponsor: Arbor Pharmaceuticals, Inc. | Conditions: Attention Deficit Hyperactivity Disorder | Phase 3 | Status: COMPLETED | Results posted: 2024-09-03